Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Other Equity
Vivos Therapeutics Inc
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Other Equity
-$180
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Other Equity
-$100.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-48%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Equity
-$16m
|
CAGR 3-Years
20%
|
CAGR 5-Years
22%
|
CAGR 10-Years
-4%
|
|
CVS Health Corp
NYSE:CVS
|
Other Equity
$196m
|
CAGR 3-Years
0%
|
CAGR 5-Years
150%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Other Equity
-$2.3B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Equity
-$185.4m
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
See Also
What is Vivos Therapeutics Inc's Other Equity?
Other Equity
-180
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Other Equity amounts to -180 USD.